StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.0
  1. Startseite
  2. /Reaktion

m-Chloroperbenzoic acid → Methyl 8-[bis-(tert-butoxycarbonyl)amino]-6-hydroxy-5,6-dihydro-pyrazolo[5,1-a]isoquinoline-7-carboxylate

HRID 595106
Notizen
Druckvorschau

Reaktionsgleichung

Reaktionsgleichung von HRID 595106
[C:1]([O:5][C:6]([N:8]([C:26]([O:28][C:29]([CH3:32])([CH3:31])[CH3:30])=[O:27])[C:9]1[C:14]([C:15]([O:17][CH3:18])=[O:16])=[C:13]([CH:19]=[CH2:20])[C:12]([C:21]2[NH:22][N:23]=[CH:24][CH:25]=2)=[CH:11][CH:10]=1)=[O:7])([CH3:4])([CH3:3])[CH3:2].C[N+]1([O-])CC[O:37]CC1.ClC1C=CC=C(C(OO)=O)C=1>C(Cl)Cl.CC(C1C=C(C=N[C@@H]2[C@@H](N=CC3C([O-])=C(C(C)(C)C)C=C(C(C)(C)C)C=3)CCCC2)C([O-])=C(C(C)(C)C)C=1)(C)C.[Cl-].[Mn+3]>[C:29]([O:28][C:26]([N:8]([C:6]([O:5][C:1]([CH3:4])([CH3:2])[CH3:3])=[O:7])[C:9]1[CH:10]=[CH:11][C:12]2[C:21]3=[CH:25][CH:24]=[N:23][N:22]3[CH2:20][CH:19]([OH:37])[C:13]=2[C:14]=1[C:15]([O:17][CH3:18])=[O:16])=[O:27])([CH3:32])([CH3:31])[CH3:30]
KomponentenReaktionsbedingungenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion

Komponenten

6

Edukt 3

HCID 70297m-Chloroperbenzoic acidHCID 82029Methyl morpholine oxideHCID 86712817methyl 6-[bis-(tert-butoxycarbonyl)amino]-3-(2H-pyrazol-3-yl)-2-vinylbenzoate2×

Produkt 1

HCID 71005652Methyl 8-[bis-(tert-butoxycarbonyl)amino]-6-hydroxy-5,6-dihydro-pyrazolo[5,1-a]isoquinoline-7-carboxylateAusbeute 11,7 %

Reagenzien, Katalysatoren, Lösungsmittel 2

HCID 10211480
(S,S)-[N,N'-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediamine]manganese(III) chloride
Katalysator
HCID 6344DichloromethaneLösungsmittel

Reaktionsbedingungen

Temperatur
0 °C

Versuchsvorschrift

To a cooled solution of methyl 6-[bis-(tert-butoxycarbonyl)amino]-3-(2H-pyrazol-3-yl)-2-vinylbenzoate (Intermediate 9, 2.4 g) in anhydrous DCM (100 mL) at 0° C. was added (S,S)-(+)-N,N′-bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediamino manganese (III) chloride (0.280 g) and N-methylmorpholine N-oxide (3.2 g). m-Chloroperbenzoic acid (3.8 g) was then added portionwise and the reaction mixture was stirred at 0° C. for 20 minutes. The resultant mixture was quenched by the addition of 2M aqueous sodium carbonate solution and the organic layer was separated, dried (MgSO4) and filtered. The filtrate was concentrated in vacuo and the residue was purified by chromatography on silica, eluting with a mixture of ethyl acetate and DCM with a gradient of 0-100%. The resultant material was repurified by chromatography on silica, eluting with a mixture of ethyl acetate and DCM with a gradient of 0-100% to give methyl 8-[bis-(tert-butoxycarbonyl)amino]-6-hydroxy-5,6-dihydro-pyrazolo[5,1-a]isoquinoline-7-carboxylate (0.290 g).

Aufarbeitung

  1. customThe resultant mixture was quenched by the addition of 2M aqueous sodium carbonate solution
  2. customthe organic layer was separated
  3. dry with materialdried (MgSO4)
  4. filtrationfiltered
  5. concentrationThe filtrate was concentrated in vacuo
  6. customthe residue was purified by chromatography on silica
  7. washeluting with a mixture of ethyl acetate and DCM with a gradient of 0-100%
  8. customThe resultant material was repurified by chromatography on silica
  9. washeluting with a mixture of ethyl acetate and DCM with a gradient of 0-100%

Quellen und Nachweise

ORD-Eintrag
ord-5426ed3f692e412ea4aa6a3a59f5736a
Quelldatensatz
uspto-grants-2016_01
DOI
10.6084/m9.figshare.5104873.v1
Patentnummer
US09242997B2

Notizen zur Reaktion

Wird geladen…

Auf dieser SeiteKomponentenReaktionsbedingungenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion